Dr. Markovic currently serves as a Senior Director, Head of U.S. Technical Regulatory Policy at Genentech, A Member of the Roche Group. In this role she is responsible for developing a strategic roadmap, including advocacy and outreach for key CMC/Quality initiatives and associated activities. Prior to this Dr. Markovic held seval positions of increasing responsibility at CDER and CBER, U.S. FDA. Her last position was Senior Science Advisor for CMC in the Office of the Center Director, CBER where she was responsible for strategic and technical/scientific regulatory review policy development including implementation and integration. She served as FDA/CBER ICH Quality Lead and was FDA topic (co)lead on ICH Q12 Expert Working Group. Ingrid trained in Biochemistry, Biophysics and Natural Products Chemistry. She holds a Ph.D. degree from University of Wisconsin, Madison and completed her post-doctoral training at U.S. National Institutes of Health in Bethesda, MD.